THE research and development of the convalescent plasma treatment is underway by the National Institute of Health under the Ministry of Health and Welfare in cooperation with Green Cross GC Pharma, a biotechnology company in South Korea to develop treatment and vaccine for COVID-19.
According to the report from the Korea Centers for Disease Control and Prevention KCDC, 562 recovered members from Shincheonji Church, a minor sect in South Korea, registered to donate plasma and 409 completed donations in July through the cooperation between KCDC and Shincheonji Church.
A statement by Hanna Moore said that early this year, about 5,000 confirmed cases were found in Shincheonji Church members with most infections from the city of Daegu, while most of them recovered from the virus with 11 deaths.
It added that major challenges of researching the effectiveness and the development of convalescent plasma treatment was due to limited supply from donors, who recovered from the virus.
According to the statement, the members of Shincheonji Church therefore decided to donate their blood plasma to accelerate development of convalescent plasma treatment, bearing physical demanding and discrimination toward the church.
-Aug 29, 2020 @ 13:21 GMT